Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Insights
  2. Events
  3. About
  4. Contact Us
MAIN/search
MAIN/Insights
Insights/
Our Latest Whitepapers

Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific. 

Learn More
Blogs, Case Studies & Podcasts

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

Discover Insights

IQVIA APAC Insight

"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.

Read The Latest Issue
MAIN/Events
Events/
Upcoming Events & Webinars

View our upcoming events and webinars.

Explore The Latest
On-Demand Webinars

Visit our library of on-demand webinars.

Discover Insights

Featured Event

"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers

Learn More
MAIN/About
About/
Newsroom

Read the latest updates and press releases.

Learn More
Career Opportunities

Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

Search Jobs

APAC FOOTPRINT

"Explore our Asia Pacific locations.

Learn more
MAIN/Contact Us
Contact Us/
White Paper
Innovative Funding Models for Treatment of Rare Diseases
A global study of new financing solutions for rare diseases
Dec 16, 2021

Get instant access

Download

Healthcare funding for rare diseases is a significant unmet need globally, due to the patient population being an inherently small and dispersed population, and often a lower priority for governments. However, there are initiatives specifically for addressing the funding gap for rare diseases, and this report provides a global review of 40 countries, from Africa, Asia Pacific (APAC), Europe, Latin America (LATAM), North America and the Middle East of the new and innovative healthcare financing solutions available.

Unlike more prevalent non-communicable diseases (e.g. cancers), only ~20% of identified funding programs can be considered innovative for rare disease. This leaves a significant opportunity for innovation in rare disease funding programs to unlock new sources of funds to improve access. In addition, there is an opportunity for multi-stakeholder engagements in the future where funding programs could be co-created among the different parties interested in strengthening patient access to RD.

Download this white paper, produced by IQVIA and Roche, or visit our dedicated Innovative Funding Trends and Models Thought Leadership page to learn more.

To read the Low and Middle Income Countries (LMICs) specific landscape report on innovative funding solutions for rare disease, click here.

This paper is also available in Spanish.

Contact Us